|
W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
| Catalog Number |
CXA360005 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Ischemia Stroke (4418)
|
| Date of Event |
06/27/2026
|
|
Type of Reportable Event
|
Death
|
|
Additional Manufacturer Narrative
|
|
H6: a review of the manufacturing records for the device verified that the lot met all pre-release specifications.As gore was unable to determine which device/device component is involved in this reportable adverse event, the following additional device will be identified in this report: catalog #cxt361414, serial #(b)(6), udi: (b)(4).W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
| |
|
Event or Problem Description
|
|
On (b)(6), 2026, the patient underwent endovascular treatment for an abdominal aortic aneurysm using the gore® excluder® conformable aaa endoprosthesis and the gore® excluder® aaa endoprosthesis, and the gore® viabahn® vbx balloon expandable endoprosthesis (vbx) devices were placed in the bilateral renal arteries using the chimney technique.The gore® dryseal flex introducer sheath was used for access, and the gore® molding & occlusion balloon catheter was used for touch-up.After all devices were placed, digital subtraction angiography(dsa) revealed slow flow in the bilateral renal arteries, and the right side vbx device was slightly kinked.A type ii endoleak was also observed in the right renal artery; therefore, an additional stent graft was placed proximally.The slow flow was slightly improved, and the physician elected to monitor it.The procedure was completed without further issues.The patient tolerated the procedure.On (b)(6), 2026, the patient developed multiple cerebral infarctions and expired.It was reported that the patient had a significant shaggy aorta.
|
| |
|
Search Alerts/Recalls
|
|
|